A few days back, Bangladesh has postponed a special drive due to a shortage of COVID-19 vaccines. A successful human trial for this new vaccine would reduce dependency on syringes, reduce the hassle of maintaining a cold chain.
This would be a great opportunity for Bangladesh to produce COVID 19 vaccines locally by securing demand for vaccination.
According to ISR scientists, the dry-powder vaccine uses manufactured Covid-19 virus proteins and can withstand temperature of up to 40 degrees Celsius. They also said a major advantage of the vaccine in development is the conditions needed to store it compared to the currently available Covid vaccines approved by the World Health Organization. "The game-changer is that you could distribute the [powder] vaccine extremely easily without the cold chain, and it can be administered without the need for healthcare providers," said a BBC report on July 26 quoting ISR founder, Ola Winquist, a professor of immunology at the Karolinska Institute, one of Sweden's leading medical universities.
/Passle/60211dc9e5416a0c14bc63d4/SearchServiceImages/2026-07-02-19-49-36-876-6a46c0d0033b1863554b58f9.jpg)
The global issues we face are challenging and interconnected. They can seem insurmountable. But if you know where to look, co-operation, positive change and hope are all around us. Build Beyond Even Better is a project that recognises the progress being made, and the amazing people who are making a difference. Share your own hopes, pledges and projects with #BBEB, or become a contributor.
Please read our BBEB Charter PDF.
/Passle/60211dc9e5416a0c14bc63d4/SearchServiceImages/2026-07-08-13-56-35-041-6a4e5713b71ad0ddcec591bd.jpg)
/Passle/60211dc9e5416a0c14bc63d4/SearchServiceImages/2026-07-02-17-02-49-101-6a4699b92a027cc45247ad98.jpg)
/Passle/60211dc9e5416a0c14bc63d4/SearchServiceImages/2026-07-07-15-51-45-769-6a4d2091387a16e32875763d.jpg)
